Companion Animal Healthcare Market: By Product Type (Drugs (Antimicrobials, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Others), Vaccines, Feed Additive (Nutritional Feed Additives, Medicinal Feed Additives), By Companion Animal Type (Feline, Canine, Equine), by Dosage Form (Orals, Parenterals, Topicals, Others), By Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, E-Commerce) and Geography

Purchase Option

$ 4400
$ 4600
$ 6900

Companion Animal Healthcare Market size was  expected to grow from USD 17.8 billion in 2022 to reach USD 24.5 billion in 2029 at a CAGR of 6.4% during forecast period 2023-29. Companion animals have been trusted for their companionship to the human throughout the history and keeping companion animals healthy is a top priority for caregivers everywhere in the world. Several studies on human and companion animal's interactions showed that owning a pet animal associated with positive health benefits. It is essential to veterinarians and caregivers to give utmost attention to companion animal health as companion animals are primary source of zoonotic diseases spread to humans and vice versa. The market is expected to grow positively over the forecast period owing to increasing rates of pet ownership, rising life expectancy for companion animals, increased number of products for treating various companion animals ailments and advances in animals healthcare services and medicines. Apart from the aforementioned factors, increasing per pet expenditure and pets are increasingly becoming part of the families in several emerging and developed economies prompting the key stakeholders to opt for better products and this in turn driving the companion animal healthcare market positively over the forecast period. However, increased treatment failures due to drug resistance, decreasing compliance to the treatments due to efficacy challenges of products are expected to hinder the market revenue growth of the market over the period of forecast.

Companion (Pet) Animal Healthcare Market Key Developments:
  • In July 2016, Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, received U.S. Food and Drug Administration's approval for BRAVECTO (fluralaner topical solution) a topical treatment for fleas and ticks for both cats and dogs.
  • In 2014, Virbac SA, signed ten years collaboration agreement with biopharmaceutical company Nexvet to develop of new monoclonal antibody-based veterinary medicines. The first medicine under the agreement between Virbac and Nexvet, NV-01, targets the control of pain associated with osteoarthritis in dogs.  

Companion Animal Healthcare Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.4%

Largest Market

North America

Fastest Growing Market

North America
Companion Animal Healthcare Market Dynamics

The Companion animal healthcare companies are expanding into new geographies and producing innovative products by exchanging skills and expertise with other key players in the increasingly competitive animal healthcare sector. Companion animal healthcare is projected to be expensive, limiting market expansion.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Companion Animal Healthcare Market Segmentation

By Animal Type
  • Feline
  • Canine
  • Equine
By Dosage Form
  • Parenterals
  • Topicals
  • Others
By Distribution Channel
  • Veterinary Pharmacies
  • Veterinary Hospitals
  • Veterinary Clinics
  • E-Commerce

Frequently Asked Questions

The companion animal healthcare market is projected to expand at a CAGR of 6.4% during the forecast period  

Elanco, Merck & Co. Inc, Virbac SA, Vetoquinol SA, Zoetis Inc.

North America is the fastest-growing region for companion animal healthcare market

One of the threats in the companion animal healthcare market is the increasing competition from generic and counterfeit medications.

Companion Animal Healthcare Market size was expected to grow from USD 17.8 billion in 2022 to reach USD 24.5 billion in 2029.

1.Executive Summary
2.Global Companion (Pet) Animal Healthcare Market Introduction 
2.1.Global Companion (Pet) Animal Healthcare Market  - Taxonomy
2.2.Global Companion (Pet) Animal Healthcare Market  - Definitions
2.2.1.Animal Type
2.2.2.Dosage Form
2.2.3.Distribution Channel
2.2.4.Region
3.Global Companion (Pet) Animal Healthcare Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Companion (Pet) Animal Healthcare Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Companion (Pet) Animal Healthcare Market  By Animal Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Feline
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Canine
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Equine
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Companion (Pet) Animal Healthcare Market  By Dosage Form, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Parenterals
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Topicals
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Companion (Pet) Animal Healthcare Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Veterinary Pharmacies
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Veterinary Hospitals
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Veterinary Clinics
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. E-Commerce
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Companion (Pet) Animal Healthcare Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Companion (Pet) Animal Healthcare Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Animal Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Feline
9.1.2.Canine
9.1.3.Equine
9.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Parenterals
9.2.2.Topicals
9.2.3.Others
9.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Veterinary Pharmacies
9.3.2.Veterinary Hospitals
9.3.3.Veterinary Clinics
9.3.4.E-Commerce
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Companion (Pet) Animal Healthcare Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Animal Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Feline
10.1.2.Canine
10.1.3.Equine
10.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Parenterals
10.2.2.Topicals
10.2.3.Others
10.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Veterinary Pharmacies
10.3.2.Veterinary Hospitals
10.3.3.Veterinary Clinics
10.3.4.E-Commerce
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Companion (Pet) Animal Healthcare Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Animal Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Feline
11.1.2.Canine
11.1.3.Equine
11.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Parenterals
11.2.2.Topicals
11.2.3.Others
11.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Veterinary Pharmacies
11.3.2.Veterinary Hospitals
11.3.3.Veterinary Clinics
11.3.4.E-Commerce
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Companion (Pet) Animal Healthcare Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Animal Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Feline
12.1.2.Canine
12.1.3.Equine
12.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Parenterals
12.2.2.Topicals
12.2.3.Others
12.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Veterinary Pharmacies
12.3.2.Veterinary Hospitals
12.3.3.Veterinary Clinics
12.3.4.E-Commerce
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Companion (Pet) Animal Healthcare Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Animal Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Feline
13.1.2.Canine
13.1.3.Equine
13.2.  Dosage Form Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Parenterals
13.2.2.Topicals
13.2.3.Others
13.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Veterinary Pharmacies
13.3.2.Veterinary Hospitals
13.3.3.Veterinary Clinics
13.3.4.E-Commerce
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Elanco
14.2.2.Merck & Co. Inc
14.2.3.Virbac SA
14.2.4.Vetoquinol SA
14.2.5.Zoetis Inc.
14.2.6.Ceva
14.2.7.Zoetis
14.2.8.Boehringer Ingelheim GmbH
14.2.9.IDEXX Laboratories, Inc.
14.2.10.Indian Immunologicals Ltd.
14.2.11.Agrolabo SpA
14.2.12.Norbrook
15. Research Methodology 
16. Appendix and Abbreviations 
  • Elanco
  • Merck & Co. Inc
  • Virbac SA
  • Vetoquinol SA
  • Zoetis Inc.
  • Ceva
  • Zoetis
  • Boehringer Ingelheim GmbH
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd.
  • Agrolabo SpA
  • Norbrook

Adjacent Markets